SRRK
Scholar Rock Holding Corp. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website cholarrock.com
- Employees(FY) 114
- ISIN US80706P1030
Performance
-14.16%
1W
-10.79%
1M
-21.3%
3M
+6.21%
6M
-33.56%
YTD
+52.69%
1Y
Profile
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, fibrosis, and iron-restricted anemia. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Investment Analysis Report: SRRK
Overview
In this investment analysis report, we will delve into the financial statements of SRRK, a company in the Health Technology sector specializing in Biotechnology. We will analyze the Balance Sheets, Income Statements, and Cashflow Statements to gain insights into the company's valuation, financial health,...
Technical Analysis of SRRK 2024-05-10
Overview:
In analyzing the technical indicators for SRRK over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been declining steadily, indi...
Recent News & Updates
- 2024-05-17 16:15
- 2024-05-17 04:15
- 2024-05-14 08:00
Scholar Rock to Host Investor Day on May 22, 2024(Business Wire)
- 2024-05-13 20:00
Scholar Rock to Host Investor Day on May 22, 2024(Businesswire)
- 2024-05-07 10:19
Scholar Rock Shares Fall on Wider-Than-Expected Q1 Loss(MT Newswires)
- 2024-05-07 07:00
- 2024-05-07 01:53
- 2024-05-06 20:52
- 2024-05-06 19:00
- 2024-05-06 19:00
- 2024-04-24 06:33
- 2024-04-12 16:15
- 2024-04-12 04:15
- 2024-03-20 05:31
- 2024-03-19 10:52
- 2024-03-19 07:00
- 2024-03-18 19:00
- 2024-03-15 16:15
- 2024-03-15 08:18
Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks(Insider Monkey)
- 2024-03-15 04:15
- 2024-03-14 20:18
- 2024-02-28 08:00
Scholar Rock to Participate in Upcoming Investor Conferences(Business Wire)
- 2024-02-27 19:00
- 2024-02-16 16:15
- 2024-02-16 03:15
- 2024-02-15 08:00
- 2024-02-14 19:00
- 2024-02-06 08:00
- 2024-02-05 19:00
- 2024-01-25 08:00
Page 1 of 5
previousnext